Agonist-promoted kappa opioid receptor (KOR) phosphorylation has behavioral endpoint-dependent and sex-specific effects

• Published in: Neuropharmacology 2022-01, Vol.202, p.108860-108860, Article 108860
• Main Authors: Huang, Peng, Chen, Chongguang, Cao, Danni, Huang, Melody, Liu-Chen, Lee-Yuan
• Format: Article
• Language: English
• Subjects: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer - pharmacology; Animals; Aversion; Behavior, Animal - drug effects; Brain - metabolism; Cells, Cultured; Female; Kappa opioid receptor; Locomotion - drug effects; Male; Mice; Mice, Mutant Strains; p-Methoxy-N-methylphenethylamine - antagonists & inhibitors; Phosphorylation; Phosphorylation - drug effects; Receptors, Opioid, kappa - agonists; Receptors, Opioid, kappa - metabolism; Sex Characteristics; Sex differences; Tolerance
• ISSN: 0028-3908; 1873-7064
• DOI: 10.1016/j.neuropharm.2021.108860

We reported previously that the selective agonist U50,488H promoted phosphorylation of the mouse kappa opioid receptor (mKOR) in vitro at four residues in the C-terminal domain. In this study, we generated a mutant mouse line in which all the four residues were mutated to Ala (K4A) to examine the in vivo functional significance of agonist-induced KOR phosphorylation. U50,488H promoted KOR phosphorylation in brains of the wildtype (WT), but not K4A, male and female mice. Autoradiography of [3H] 69,593 binding to KOR in brain sections showed that WT and K4A mice had similar KOR distribution and expression levels in brain regions without sex differences. In K4A mice, U50,488H inhibited compound 48/80-induced scratching and attenuated novelty-induced hyperlocomotion to similar extents as in WT mice without sex differences. Interestingly, repeated pretreatment with U50,488H (80 mg/kg, s.c.) resulted in profound tolerance to the anti-scratch effects of U50,488H (5 mg/kg, s.c.) in WT mice of both sexes and female K4A mice, while in male K4A mice tolerance was attenuated. Moreover, U50,488H (2 mg/kg) induced conditioned place aversion (CPA) in WT mice of both sexes and male K4A mice, but not in female K4A mice. In contrast, U50,488H (5 mg/kg) caused CPA in male, but not female, mice, regardless of genotype. Thus, agonist-promoted KOR phosphorylation plays important roles in U50,488H-induced tolerance and CPA in a sex-dependent manner, without affecting acute U50,488H-induced anti-pruritic and hypo-locomotor effects. These results are the first to demonstrate sex differences in the effects of GPCR phosphorylation on the GPCR-mediated behaviors. •KOR phosphorylation has behavioral endpoint-dependent and sex-specific effects.•It played roles in U50,488H-induced tolerance in male mice only.•It played roles in U50,488H-induced CPA in female mice only.•It didn't affect U50,488H-induced antipruritic and hypo-locomotor effects.